Tower Wealth Advisory

Newswire

Live Long & Prosper: Better Health, Better Wealth

TW-WA Article

Many of us remember the classic Star Trek mantra ‘live long and prosper,’ which may be worth reflection as we enter the leisurely summer months. The keys to a longer and more prosperous life are often rooted in fundamentals that include both health and wealth.

Better Health, Better Wealth

Not surprisingly, physical, mental and financial well-being are interconnected. Perhaps one of the simplest associations between health and wealth is the cost of maintaining unhealthy habits. Consider that kicking a $5 per day smoking habit would save $1,825 annually, which could accumulate to over $150,000 in 30 years at an annual rate of return of 6 percent. While we are fortunate in Canada to have a social system that supports healthcare costs, unlike the U.S., tax payers still bear the burden. The latest reports suggest that chronic diseases, many preventable, account for more than $80 billion in annual healthcare costs in Canada.1

However, the connections extend beyond the financial burden of unhealthy habits. Studies continue to show a strong correlation between physical fitness and financial fitness.2 To some extent, this is because greater income and wealth provide resources to protect and improve health. Yet, it may go deeper than just resources. Accumulating wealth and improving health are guided by similar principles — both require consistency and discipline. Whether it’s saving and investing to grow a future nest egg or reshaping healthy habits through physical activity or better eating, consistency can pay dividends down the road. The benefits of these investments can compound over time. Often , people fail in their health and wealth goals because they succumb to immediate temptations rather than stay focused on longer-term objectives. As one expert noted, when it comes to health, “dollar-cost average your energy into healthful activities and the returns might surprise you.” The same can be said about investing.

The 100-Year-Old Marathoner: It’s Never Too Late to Start

Many of us spend the first 20 to 30 years of our working lives prioritizing wealth accumulation, often directing less of our attention to our health. However, the good news is that it’s never too late to shift focus. While starting to save for retirement at age 70 is never idea , playing more attention to our health can begin at any age. There are inspiring examples: Richard Morgan, a 93-year-old, four-time rowing champion with the fitness level of a 40-year-old, didn’t begin exercise training until age 73. Feeling “somewhat at loose ends” in retirement, he started training after attending a rowing practice with his grandson.3 Similarly, the world’s oldest marathoner ran his last marathon at age 100 in Toronto, having taken up running at the ripe age of 89 to overcome grie.4f Better lifestyle choices are also linked to greater longevity. With the rising prevalence of diseases like obesity, Alzheimer’s and early on set cancer, many studies suggest that basic lifestyle changes including exercise, healthy diet and adequate sleep may be keys to addressing their disproportional growth.

Indeed, adopting consistent and disciplined approaches — in both health and wealth management — can yield profound and far reaching returns. It’s all good food for thought in the pursuit of living long and prospering.

1. https://www150.statcan.gc.ca/n1/pub/82-003-x/82-003-x2020010-eng.htm
2. https://internationalservices.hsbc.com/content/dam/hsbc/hsbcis/docs/reports/asia-wealth/hsbc-life-factor-study.pdf; 
3. https://www.washingtonpost.com/wellness/2024/01/16/fitness-aging-richard-morgan/;
4. https://olympics.com/en/news/who-is-fauja-singh-oldest-indian-origin-british-marathon-runner

Health, Wealth & Investing — The Ozempic Effect

The healthcare industry is experiencing a remarkable period of innovation and growth. One area garnering significant attention is the development of weight loss drugs that mimic the hormone GLP-1. These drugs help regulate hunger to combat obesity, which affects around 30 percent of Canadian and 40 percent of U.S. adults. This advancement has not only attracted considerable interest from celebrities and the media, but has also led to substantial increases in the share prices of pharmaceutical companies producing these drugs. Some equity values have risen by double digits over the past year, reflecting the market’s confidence in this burgeoning field. Goldman Sachs, a leading investment banking firm, projects that the global market for obesity drugs could reach $100 billion by 2030.5

Some suggest we are at a pivotal moment, marking the early stages of what could be a revolutionary period in the development and commercialization of new drugs. This is being fueled by significant advances in biotechnology, artificial intelligence (AI) and information technology, and is expected to support the treatment of a wide range of conditions, including obesity, diabetes, Alzheimer’s and more. It’s an exciting time for innovation and disruption in this space and, for investors, the potential transformation may provide opportunities.

5. https://www.goldmansachs.com/intelligence/pages/anti-obesity-drug-arket.html

The information contained herein has been provided for information purposes only. Graphs, charts and other numbers are used for illustrative purposes only and do not reflect future values or future performance of any investment. The information has been provided by J. Hirasawa & Associates and is drawn from sources believed to be reliable. The information does not provide financial, legal, tax or investment advice. Particular investment, tax, or trading strategies should be evaluated relative to each individual’s objectives and risk tolerance. This does not constitute a recommendation or solicitation to buy or sell securities of any kind. Market conditions may change which may impact the information contained in this document. Wellington-Altus Private Wealth Inc. (WAPW) and the authors do not guarantee the accuracy or completeness of the information contained herein, nor does WAPW, nor the authors, assume any liability for any loss that may result from the reliance by any person upon any such information or opinions. Before acting on any of the above, please contact me for individual financial advice based on your personal circumstances. WAPW is a member of the Canadian Investor Protection Fund and the Investment Industry Regulatory Organization of Canada.

Insurance products are provided through Wellington-Altus Insurance Inc.
© 2024, Wellington-Altus Private Wealth Inc. ALL RIGHTS RESERVED. NO USE OR REPRODUCTION WITHOUT PERMISSION.
www.wellington-altus.ca
If you no longer wish to receive commercial electronic messages from Wellington-Altus Private Wealth Inc., please send an email to unsubscribe@wellington-altus.ca

Recent Posts

A Primer on Structured Notes

With the return of equity market volatility and the high concentration among a handful of mega-cap names, alongside
volatile bond markets as central banks have raised and lowered interest rates, there has been significant interest in structured notes.

Read More »

Higher Rates for Longer?

It has been termed ‘the great renewal’: A significant number of Canadian mortgages are coming up for renewal. By one account, around 2.2 million mortgages, or 45 percent of all outstanding mortgages, are set to face higher interest rates this year and next.

Read More »

U.S. Election Special Market Insights: American System 2.0

As the Roman philosopher and statesman Lucius Annaeus Seneca once said: “Yield not to adversity; trust not to prosperity; keep before your eyes the full scope of Fortune’s power, as if she would surely do whatever is in her power to do.” This sentiment resonates as we examine the current economic landscape shaped by Donald Trump’s victory in the 2024 U.S. presidential election.

Read More »

Your Questions Answered

With the (proposed*) increase to the capital gains inclusion rate in 2024, there have been various questions from
investors about tax planning. Here are two that relate to year-end planning.

Read More »

The opinions contained herein are the opinions of the author and readers should not assume they reflect the opinions or recommendations of Wellington-Altus Private Wealth. Assumptions, opinions and information constitute the author’s judgement as of the date this material and subject to change without notice. We do not warrant the completeness or accuracy of this material, and it should not be relied upon as such. Before acting on any recommendation, you should consider whether it is suitable for your particular circumstances and, if necessary, seek professional advice. Graphs and charts are used for illustrative purposes only and do not reflect future values or future performance of any investment. The information does not provide financial, legal, tax or investment advice. Particular investment, tax, or trading strategies should be evaluated relative to each individual’s objectives and risk tolerance. All third party products and services referred to or advertised in this presentation are sold by the company or organization named. While these products or services may serve as valuable aids to the independent investor, WAPW does not specifically endorse any of these products or services. The third party products and services referred to, or advertised in this presentation, are available as a convenience to its customers only, and WAPW is not liable for any claims, losses or damages however arising out of any purchase or use of third party products or services. All insurance products and services are offered by life licensed advisors of Wellington-Altus.